←
Emily K. Sims358 posts
Emily K. Sims avatar

Emily K. Sims

@EmKSims

Physician scientist at Indiana University

◷ Joined June 2018▧ 42 Photos and videos
Emily K. Sims avatar
Emily K. Sims@EmKSims·23 Jul 2025

3. Risk scores like HbA1c and metabolic indices performed better in adults 4. Unique patterns suggest a need for age-tailored screening and follow-up

Emily K. Sims avatar
Emily K. Sims@EmKSims·23 Jul 2025

2. Unlike those were were single Ab positive or met stage 1 T1D criteria, adults with stage 2 T1D at screening progressed at the same rate as children (78% in 5 years)

Emily K. Sims avatar
Emily K. Sims@EmKSims·23 Jul 2025

We found important differences exist in screening and progression amongst children and adults. For example: 1. Adults were more likely to screen single Ab positive compared to kids

Emily K. Sims avatar
Emily K. Sims@EmKSims·18 Nov 2024

Really excited to share this super translational project from rockstar @chaipoorva ! Islets and T cells and EVs- what more could you want ❤️?

Beta cell extracellular vesicles carry PD-L1 and suppress CD8+ T cells. EV PD-L1 is increased in AAB+ individuals, correlating with residual beta cell function. Potential #biomarker for #T1D heterogeneity. #Diabetes @IUSweetTweets @emksims @chaipoorva tinyurl.com/4pe2hbvb

Post attachment
Emily K. Sims avatar
Emily K. Sims@EmKSims·24 Apr 2024

Great work by @JacobsenLM and @Heba_T1D supporting the idea that metabolic endpoints can give us a quick readout of T1D disease modification. And we know based on @DrPeteTaylor and Colin Dayan's data that these changes have clinical relevance for our patients with T1D!

@T1D_TrialNet identifies earlier trial end points that demonstrate a beneficial treatment effect at 6 months and predict benefit out to 12 months. This could allow for shorter early phase trials or adaptive designs. @ADA_Pubs Read Here➡️doi.org/10.2337/dc24-0171

Post attachment